These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9228715)

  • 1. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
    Schnaidt M; Northoff H; Wernet D
    Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
    Friedman DF; Lukas MB; Jawad A; Larson PJ; Ohene-Frempong K; Manno CS
    Blood; 1996 Oct; 88(8):3216-22. PubMed ID: 8874223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
    Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
    Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunization as a problem for platelet transfusion.
    Bonacossa IA
    Transfus Med Rev; 1990 Apr; 4(2):144-8. PubMed ID: 2134622
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet-specific antibodies in transfused patients.
    Uhrynowska M; Zupańska B
    Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet alloantibodies in transfused patients.
    Kiefel V; König C; Kroll H; Santoso S
    Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
    Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
    Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of platelet alloimmunization: management and prevention.
    Kickler TS
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):8-18. PubMed ID: 2134640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
    Godeau B; Fromont P; Seror T; Duedari N; Bierling P
    Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and causes of refractoriness in multiply transfused patients.
    Legler TJ; Fischer I; Dittmann J; Simson G; Lynen R; Humpe A; Riggert J; Schleyer E; Kern W; Hiddemann W; Köhler M
    Ann Hematol; 1997 Apr; 74(4):185-9. PubMed ID: 9174547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
    Lo SC; Lin DT; Lin SW; Chang JS
    J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.